Investigational drugs reduce risk of death from Ebola virus disease
Study leaders publish results from NIH-DRC-WHO clinical trial of four experimental therapiesCredit: ALIMA The investigational therapeutics mAb114 and REGN-EB3 offer patients a greater chance of...

















